Pharmaceutical brand naming pro. Pioneered modern drug naming practices. Helped create over 100 approved biopharma brand names. Founder of Gary Martin Group. Passionate about helping clients advance their goals.
Brand names function as free sound bites for your products (even before marketing approval). I am a biopharma naming pro with three decades of successful naming, nomenclature, and branding experience. I have helped create hundreds of approved biopharma brand names, including Viagra®, Enbrel®, and Perjeta®. Currently as president of Gary Martin Group, my focus is on providing naming guidance to the biopharma industry. I have a passion for helping companies name their drugs, and I look forward to hearing your brief.
The nonproprietary name, or "generic name," is a necessary and unique designation for every pharmaceutical substance or biologic product. It is requested on FDA applications and in drug substance chemical descriptions, and it also appears with the company's trade name on drug labels. Because the guidelines to develop a nonproprietary name are tricky, and the approval process is complicated, many nonproprietary names are initially rejected. I have helped many companies create nonproprietary names, and I can help you navigate these challenges successfully.
Brand your clinical trials and build your scientific position. The clinical trial phases present excellent opportunities for explaining your science and planting the seed of a novel molecule. I have helped many biopharma companies name their clinical trials and develop their visual identity, and I look forward to the opportunity to talk to you.
Biotechs and life science start-ups are passionate about their scientific discoveries. By taking a proactive approach to naming, they can better appeal to investors, attract potential partners and communicate with the healthcare community. As founder of Gary Martin Group, my focus is on providing pharmaceutical naming guidance to small, emerging biotech companies. I have a passion for helping companies name themselves, name their drugs, develop their clinical trial branding/naming, and create USAN/INNs. Let’s discuss how nomenclature can advance your scientific dreams into commercial reality.
Gary knows drug naming in and out. Definitely an expert on the topic.
Gary provides a very professional and expert service on a branding and naming project and I would strong recommend him for such projects in the future.
